Amy Phyllis Fitzpatrick

US Patent:

20090163580, Jun 25, 2009

Filed:

Dec 18, 2008

Appl. No.:

12/317048

Inventors:

Michael Todd Yatcilla - Los Angeles CA, US
Dallas Clouatre - Berkeley CA, US
Edward Anthony Byrd - San Francisci CA, US
Amy Addington Fitzpatrick - Kingsport TN, US

International Classification:

A61K 31/05
A61K 31/085
A61K 31/353
A61P 25/28
A61P 25/16
A61P 9/00
A61P 35/00
A61P 19/10
A61P 1/16
A61P 1/18

US Classification:

514456, 514733, 514720

Abstract:

Formulations and methods of treatment and putative prevention for aging (anti-aging composition) and for diseases or conditions of all reactive oxygen species-dependant illnesses, such as Alzheimer's disease, Parkinson's disease, diabetes mellitus, cardiovascular disease, cancer, hepatitis, and disorders associated with estrogen deficiencies including osteoporosis and breast cancer and for improving athletic performance of humans include resveratrol and two (2) or more of the following features or additional active ingredients: (1) slow release formulation of resveratrol; (2) pterostilbene; (3) quercetin; (4) fisetin, and (5) naringenin. Slow release is defined for the purposes of the present invention as releasing 95% of the active agent or agents in eight (8) hours through normal human gastrointestinal absorption.